SeaSpine Holdings Corporation (SPNE) Posts Earnings Results, Beats Expectations By $0.11 EPS
SeaSpine Holdings Corporation (NASDAQ:SPNE) announced its quarterly earnings data on Thursday. The medical equipment provider reported ($0.68) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.79) by $0.11, reports. SeaSpine Holdings Corporation had a negative return on equity of 34.71% and a negative net margin of 31.16%.
Shares of SeaSpine Holdings Corporation (SPNE) traded up 12.61% during midday trading on Friday, hitting $12.95. The stock had a trading volume of 69,027 shares. The company’s 50-day moving average price is $11.42 and its 200-day moving average price is $8.94. The firm’s market cap is $152.02 million. SeaSpine Holdings Corporation has a 12-month low of $6.31 and a 12-month high of $13.46.
TRADEMARK VIOLATION WARNING: “SeaSpine Holdings Corporation (SPNE) Posts Earnings Results, Beats Expectations By $0.11 EPS” was originally reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/08/04/seaspine-holdings-corporation-spne-posts-earnings-results-beats-expectations-by-0-11-eps.html.
A number of equities research analysts have recently commented on the company. BTIG Research assumed coverage on SeaSpine Holdings Corporation in a research report on Tuesday, June 20th. They issued a “buy” rating for the company. ValuEngine raised SeaSpine Holdings Corporation from a “strong sell” rating to a “sell” rating in a research report on Friday, June 2nd. Finally, HC Wainwright assumed coverage on SeaSpine Holdings Corporation in a research report on Monday, July 10th. They issued a “buy” rating and a $15.00 price objective for the company.
SeaSpine Holdings Corporation Company Profile
SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment.
Receive News & Ratings for SeaSpine Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine Holdings Corporation and related companies with MarketBeat.com's FREE daily email newsletter.